WhiteLab Genomics (WLG) develops and leverages an AI-powered platform to accelerate, optimize and derisk R&D in cell and gene therapy. WLG utilizes its platform for target identification and vector design (viral and non-viral), as well as payload design and bioproduction optimization. WLG boast a robust portfolio of collaboration with academia, biotechs, and pharmaceutical leaders.
